Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 2
2015 3
2016 3
2017 8
2018 4
2019 5
2020 6
2021 3
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
[Epidemiology of pancreatic cancer].
Drouillard A, Manfredi S, Lepage C, Bouvier AM. Drouillard A, et al. Bull Cancer. 2018 Jan;105(1):63-69. doi: 10.1016/j.bulcan.2017.11.004. Epub 2017 Dec 19. Bull Cancer. 2018. PMID: 29273548 Review. French.
Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma.
Piquemal D, Bruno R, Bournet B, Ghiringhelli F, Noguier F, Canivet C, Bertaut A, Pierrat F, Evesque L, Gamez A, Cros J, Rederstorff E, Petit E, Adnet J, Saint A, Drouillard A, Kempf E, Soularue E, Vincent J, Baumgaertner I, Hennequin A, Tournigand C, Lopez Trabada Ataz D, Bengrine L, Lepage C, Manfredi S, Afchain P, Trouilloud I, Gagnaire A, LoConte NK, Bachet JB. Piquemal D, et al. Among authors: drouillard a. J Gastrointest Oncol. 2023 Apr 29;14(2):997-1007. doi: 10.21037/jgo-22-946. Epub 2023 Apr 10. J Gastrointest Oncol. 2023. PMID: 37201091 Free PMC article.
mTOR Activation Underlies Enhanced B Cell Proliferation and Autoimmunity in PrkcdG510S/G510S Mice.
Moreews M, Mathieu AL, Pouxvielh K, Reuschlé Q, Drouillard A, Dessay P, Meignien M, Zhang J, Fallone L, Rousseaux N, Ainouze M, Rey A, Omarjee O, Decembre E, Lenief V, Djebali S, Thaunat O, Dreux M, Genestier L, Defrance T, Soulas-Sprauel P, Marçais A, Walzer T, Belot A. Moreews M, et al. Among authors: drouillard a. J Immunol. 2023 May 1;210(9):1209-1221. doi: 10.4049/jimmunol.2200818. J Immunol. 2023. PMID: 36961448
Epidemiology and risk factors for oesophageal adenocarcinoma.
Lepage C, Drouillard A, Jouve JL, Faivre J. Lepage C, et al. Among authors: drouillard a. Dig Liver Dis. 2013 Aug;45(8):625-9. doi: 10.1016/j.dld.2012.12.020. Epub 2013 Feb 28. Dig Liver Dis. 2013. PMID: 23453359 Review.
Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study.
Auvray Kuentz M, Hautefeuille V, de Mestier L, Coutzac C, Lecomte T, Nardon V, Artru P, Turpin A, Drouillard A, Malka D, Tran-Minh ML, Trouilloud I, Lièvre A, Williet N, Pernot S, Touchefeu Y, Taieb J, Hammel P, Zaanan A. Auvray Kuentz M, et al. Among authors: drouillard a. Int J Cancer. 2023 May 1;152(9):1894-1902. doi: 10.1002/ijc.34414. Epub 2023 Jan 3. Int J Cancer. 2023. PMID: 36562310 Free article.
Immune-checkpoint inhibition for digestive cancers.
Manfredi S, Drouillard A. Manfredi S, et al. Among authors: drouillard a. Lancet Oncol. 2017 May;18(5):561-562. doi: 10.1016/S1470-2045(17)30188-2. Epub 2017 Mar 15. Lancet Oncol. 2017. PMID: 28314687 No abstract available.
Novel Potent Selective Orally Active S1P5 Receptor Antagonists.
Ma B, Guckian KM, Liu XG, Yang C, Li B, Scannevin R, Mingueneau M, Drouillard A, Walzer T. Ma B, et al. Among authors: drouillard a. ACS Med Chem Lett. 2021 Jan 15;12(3):351-355. doi: 10.1021/acsmedchemlett.0c00631. eCollection 2021 Mar 11. ACS Med Chem Lett. 2021. PMID: 33738061 Free PMC article.
37 results